Personalis Inc(PSNL) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.

Current Price

$22.75

RSI

60.844

February 25, 2021
11M
-3.4M

11.138 %
19.977 %
-100.617 %
-36.536 %

$78,646,000
$62,370,000
$37,774,000
$9,393,000
26.096 %
65.114 %
302.151 %

$-41,223,000
$-25,075,000
$-19,879,000
$-23,593,000
-39.172 %
-20.722 %
18.683 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.